Effectiveness of daunomycin (NSC-82151) against experimental tumors.
D000818:Animals; D003630:Daunorubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008297:Male; D051379:Mice; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D003630:Daunorubicin